Skip to content

Comparison of systematic treatment algorithms with treatment as usual in patients with unipolar depression

Comparison of systematic treatment algorithms with treatment as usual in patients with unipolar depression - Algorithmusstudie

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000161
Enrollment
450
Registered
2009-07-23
Start date
2000-08-21
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33

Interventions

Group 1: SSTR I/! (standardized stepwise drug treatment regimen): lithium augmentation in step 2 in case of nonresponse to 4 weeks antidepressant monotherapy steps of the treatment algorithm in case

Sponsors

Charité Universitätsmedizin Berlin, Campus Charité Mitte
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: major depressive episode, with or wíthout psychotic symtoms (ICD-10: F32.0, F32.1, F32.2, F32.3) recurrent depressive disorder, with or without psychotic symptoms (ICD-10: F33.0, F33.1, F33.2, F33.3, F33.8, F33.9) HAMD-score > 15 age 18-70 years informed consent

Exclusion criteria

Exclusion criteria: bipolar affective disorder (ICD-10: F31) depression caused by another medical condition, pregnancy/breastfeeding, pre-existing long-term medication treatment that could not be discontinued severe medical condition which presented a limitation for any of the possible treatments in the study admission by court order

Design outcomes

Primary

MeasureTime frame
time to remission (HAMD-21 < = 9 Punkte) HAMD: Hamilton Depression Rating Scale

Secondary

MeasureTime frame
- time to response (HAMD-reduction > 50%) - number of remitted patients (HAMD-21 50%) - number of strategy changes (switches) - duration of inpatient treatment - direct and indirect costs

Countries

Germany

Contacts

Public ContactMazda Adli

Charité Universitätsmedizin, Campus Charité Mitte Klinik für Psychiatrie und Psychotherapie

mazda.adli@charite.de+49 30 450 570003

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 31, 2026